RxDoctor Payments Data

Jossie McCloud, DO

Family Medicine · Jacksonville, FLNPI 1033161799

Payments from drug & device makers

$1,378in general payments, 2019–2025

Across 24 payments — averaging $57.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$483
  • Johnson & Johnson$443
  • Amgen$112
  • Hologic Sales And Service, LLC$93
  • Boehringer Ingelheim$50
  • Lilly USA, LLC$45
  • plus $152 from 8 others

What the payments were for

  • Food & beverage$1,378100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,378 in reported general payments places this provider in the 65th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$6,852
Medicare patients
56
Services billed
64

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin39$22,600
EntrestoSacubitril/Valsartan26$5,081
Atorvastatin Calcium52$790
Losartan Potassium44$662
ClopidogrelClopidogrel Bisulfate26$592
Omeprazole38$568
Irbesartan11$450
Albuterol Sulfate HfaAlbuterol Sulfate14$364
Famotidine11$347
Gabapentin17$342
Pantoprazole Sodium14$300
Metformin Hcl22$266
Amlodipine Besylate48$205
Lisinopril31$167
Levothyroxine Sodium22$129

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$50$22,60039 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Jacksonville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →